ArticlePharmaceutics2019
Magnetoliposomes Containing Calcium Ferrite Nanoparticles for Applications in Breast Cancer Therapy.
Abstract read
In one paragraph
Article in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- A Compendium of Magnetic Nanoparticle Essentials: A Comprehensive Guide for Beginners and Experts.Pharmaceutics · 2025Review
- Rational Drug Discovery for Isoxazole Based VEGFR2 Inhibition.Current drug discovery technologies · 2025Article
- Untangling Breast Cancer: Trailing Towards Nanoformulations-based Drug Development.Recent patents on nanotechnology · 2025Review
- Surface Engineering of Magnetic Iron Oxide Nanoparticles for Breast Cancer Diagnostics and Drug Delivery.International journal of nanomedicine · 2024Review
- Development of pH-Sensitive Magnetoliposomes Containing Shape Anisotropic Nanoparticles for Potential Application in Combined Cancer Therapy.Nanomaterials (Basel, Switzerland) · 2023Article
- Optimisation of the Flame Spheroidisation Process for the Rapid Manufacture of FeMolecules (Basel, Switzerland) · 2023Article
- What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review.Advanced pharmaceutical bulletin · 2023Review
- Doxorubicin Loaded Thermosensitive Magneto-Liposomes Obtained by a Gel Hydration Technique: Characterization and In Vitro Magneto-Chemotherapeutic Effect Assessment.Pharmaceutics · 2022Article
- Oxidative Precipitation Synthesis of Calcium-Doped Manganese Ferrite Nanoparticles for Magnetic Hyperthermia.International journal of molecular sciences · 2022Article
- The Therapeutic Potential of Chemo/Thermotherapy with Magnetoliposomes for Cancer Treatment.Pharmaceutics · 2022Review
- Development of Thermo- and pH-Sensitive Liposomal Magnetic Carriers for New Potential Antitumor Thienopyridine Derivatives.Materials (Basel, Switzerland) · 2022Article
- Microfluidic Synthesis and Purification of Magnetoliposomes for Potential Applications in the Gastrointestinal Delivery of Difficult-to-Transport Drugs.Pharmaceutics · 2022Article
- Magnetoliposomes Based on Shape Anisotropic Calcium/Magnesium Ferrite Nanoparticles as Nanocarriers for Doxorubicin.Pharmaceutics · 2021Article
- Evaluation of Physicochemical Properties of Amphiphilic 1,4-Dihydropyridines and Preparation of Magnetoliposomes.Nanomaterials (Basel, Switzerland) · 2021Article
- Cytotoxic Plant Extracts towards Insect Cells: Bioactivity and Nanoencapsulation Studies for Application as Biopesticides.Molecules (Basel, Switzerland) · 2020Article
- Magnetoliposomes Incorporated in Peptide-Based Hydrogels: Towards Development of Magnetolipogels.Nanomaterials (Basel, Switzerland) · 2020Article
- Stealth Magnetoliposomes Based on Calcium-Substituted Magnesium Ferrite Nanoparticles for Curcumin Transport and Release.International journal of molecular sciences · 2020Article
- Magnetic Nanoparticles of Zinc/Calcium Ferrite Decorated with Silver for Photodegradation of Dyes.Materials (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Daniela S M PereiraCentre of Physics (CFUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. daniela.s.pereira30@gmail.com.
Beatriz D CardosoCentre of Physics (CFUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. beatrizdiascardoso94@gmail.com.
Ana Rita O RodriguesCentre of Physics (CFUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. ritarodrigues@fisica.uminho.pt.
Carlos O AmorimPhysics Department and CICECO, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal. amorim5@ua.pt.
Vítor S AmaralPhysics Department and CICECO, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal. vamaral@ua.pt.
Bernardo G AlmeidaCentre of Physics (CFUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. bernardo@fisica.uminho.pt.
Maria-João R P QueirozCentre of Chemistry, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. mjrpq@quimica.uminho.pt.
Olga MartinhoLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. olgamartinho@med.uminho.pt.
Fátima BaltazarLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. fbaltazar@med.uminho.pt.
Ricardo C CalhelhaMountain Research Centre, Polytechnic Institute of Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal. calhelha@ipb.pt.
Isabel C F R FerreiraMountain Research Centre, Polytechnic Institute of Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal. iferreira@ipb.pt.
Paulo J G CoutinhoCentre of Physics (CFUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. pcoutinho@fisica.uminho.pt.
Elisabete M S CastanheiraCentre of Physics (CFUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. ecoutinho@fisica.uminho.pt.
Funding
Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanomaR44CA141936 · NCI · MOLECULAR INSIGHT PHARMACEUTICALS, INC. · PI BABICH, JOHN W · 2009 to 2011
$1.5MFundação para a Ciência e a Tecnologia PTDC/QUI-QFI/28020/2017 (POCI-01-0145-FEDER-028020)Fundação para a Ciência e a Tecnologia SFRH/BD/141936/2018Fundação para a Ciência e a Tecnologia UID/FIS/04650/2013Fundação para a Ciência e a Tecnologia UID/FIS/04650/2019Fundação para a Ciência e a Tecnologia UID/QUI/00686/2016Fundação para a Ciência e a Tecnologia UID/QUI/00686/2019
Abstract
Magnetoliposomes containing calcium ferrite (CaFe
Indexed as
breast cancer therapycalcium ferrite nanoparticlesmagnetoliposomesnew antitumor drugsthienopyridine derivatives
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.